Publication
Promising Immuno-Oncology Treatments Beyond the 2018 Nobel Prize
| dc.contributor.author | Castelo-Branco, L | |
| dc.contributor.author | Pires Silva, I | |
| dc.contributor.author | Canhão, H | |
| dc.contributor.author | Awada, A | |
| dc.date.accessioned | 2019-05-16T14:37:52Z | |
| dc.date.available | 2019-05-16T14:37:52Z | |
| dc.date.issued | 2019-04-30 | |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Acta Med Port. 2019 Apr 30;32(4):251-257. | pt_PT |
| dc.identifier.doi | 10.20344/amp.12040 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.17/3251 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Ordem dos Médicos | pt_PT |
| dc.subject | CHLC REUM | pt_PT |
| dc.subject | Antibodies, Monoclonal/therapeutic use | pt_PT |
| dc.subject | CTLA-4 Antigen/antagonists & inhibitors | pt_PT |
| dc.subject | Cancer Vaccines/therapeutic use | pt_PT |
| dc.subject | Immunotherapy, Adoptive/methods | pt_PT |
| dc.subject | Lymphocyte Activation | pt_PT |
| dc.subject | Melanoma/therapy | |
| dc.subject | Neoplasms/therapy | |
| dc.subject | Nobel Prize | |
| dc.subject | Programmed Cell Death 1 Receptor/antagonists & inhibitors | |
| dc.subject | Skin Neoplasms/therapy | |
| dc.title | Promising Immuno-Oncology Treatments Beyond the 2018 Nobel Prize | pt_PT |
| dc.title.alternative | Tratamentos Promissores de Imuno-Oncologia Para Além do Prémio Nobel 2018 | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 257 | pt_PT |
| oaire.citation.issue | 4 | pt_PT |
| oaire.citation.startPage | 251 | pt_PT |
| oaire.citation.title | Acta Médica Portuguesa | pt_PT |
| oaire.citation.volume | 32 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |